Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
technical and funding issues
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Objective: To compare success rates of biodentine partial pulpotomy versus formocresol pulpotomy treatment of pulpally exposed lower primary molars.
After caries removal resulted in a pulp exposure, the pulp at the exposed area is amputated to a depth of 2 mm. The wound surface is irrigated and dried. After homeostasis is obtained, an assistant drew lots to randomly allocate the case to either the biodentine partial pulpotomy (PP) or the formocresol pulpotomy (FP) group.
The follow-up for clinical and radiographic evaluation will be carried out at 6-month intervals.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Partial pulpotomy with biodentine | Experimental | Biodentine is gently applied to the pulp stumps |
|
| Formocresol pulpotomy | Other | A cotton pellet moistened with formocresol (1: 5 Buckley's solution) is placed on the amputated pulp for 5 min. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| partial pulpotomy with biodentine | Procedure | After caries removal resulted in a pulp exposure, the pulp at the exposed area is amputated to a depth of 2 mm. The wound surface is irrigated and dried. After homeostasis is obtained, biodentine is gently applied to the wound surface, and then covered with reinforced zinc oxide-eugenol |
| Measure | Description | Time Frame |
|---|---|---|
| partial pulpotomy clinical success rate | Treatment is considered a clinical failure if one or more of the following signs are observed: pain, abscess or sinus opening, tenderness upon percussion, or abnormal tooth mobility. The treatment is regarded successful if clinical evaluation does not indicate any signs of failure. | 6-month intervals, up to 2 years. From date of randomization until the date of first documented failure or up to 24 months |
| partial pulpotomy radiographic success rate | For radiographic evaluation, the treatment is rated as a failure when one or more of the following signs are present: furcation or periapical radiolucency, pathologic external root resorption, or internal resorption. The treatment is regarded successful if radiographic evaluation does not indicate any signs of failure. | 6-month intervals, up to 2 years. From date of randomization until the date of first documented failure or up to 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Formocresol pulpotomy clinical success rate | Treatment is considered a clinical failure if one or more of the following signs are observed: pain, abscess or sinus opening, tenderness upon percussion, or abnormal tooth mobility. The treatment is regarded successful if clinical evaluation does not indicate any signs of failure. | 6-month intervals, up to 2 years. From date of randomization until the date of first documented failure or up to 24 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C506393 | tricalcium silicate |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Formocresol pulpotomy | Procedure | Following removal of the coronal pulp and achievement of homeostasis, a cotton pellet moistened with formocresol (1: 5 Buckley's solution) is placed on the amputated pulp for 5 min. The pulp stumps is then covered by IRM. |
|
| Formocresol pulpotomy radiographic success rate | For radiographic evaluation, the treatment is rated as a failure when one or more of the following signs are present: furcation or periapical radiolucency, pathologic external root resorption, or internal resorption. The treatment is regarded successful if radiographic evaluation does not indicate any signs of failure. | 6-month intervals, up to 2 years. From date of randomization until the date of first documented failure or up to 24 months |